Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review

Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - Analyst’s summarization of the company’s business strategy.
• SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sartorius AG (Sartorius) is a medical device company that offers laboratory and process technology equipment. The company's product portfolio includes cell lines; cell culture media; reagents; bioreactors; technologies for the separation, purification, and concentration of biological intermediates and end products; solutions for storage and transportation; laboratory balances; pipettes; lab water systems; and consumables, such as filters and microbiological test kits; among others. It also offers services such as bioprocess consulting and engineering, cell culture media services, biologics testing, instrument service, and validation services. Sartorius serves pharmaceutical and biotechnology companies, academic research facilities, and quality control labs in the chemical and food industries. The company's products are used in applications such as drug development, biopharmaceutical manufacturing, and quality control. Sartorius is headquartered in Gottingen, Niedersachsen, Germany.

Sartorius AG Key Recent Developments

• Jun 24, 2025: Kicking Off, Process Intensified. Drug Manufacturing Accelerated. The Sartorius PI Forum opens in Boston -- shaping biomanufacturing's future
• Jun 17, 2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
• May 02, 2025: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
• Apr 16, 2025: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter Read Media Release

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company